title: Expression of an oncofetal protein (OFP) in rat and human leukemia cells.
abstract: A unique oncofetal protein (OFP) previously identified in rat fetal tissue and rat and human solid tumors, is now shown to be present in rat and human leukemia cells by use of a monoclonal antibody-based assay. Using a highly specific anti-rat OFP monoclonal antibody OFP has been unquivocally immunolocalized to the cytoplasm of the rat leukemia cells. The factor is rapidly released to the circulation as 50 and 55 kD species which share the immunological determinants. When leukemia cells are transplanted to normal rats, OFP increases in the circulation in a biphasic manner which may be due to immune clearance since circulating anti-OFP antibodies have been demonstrated. Induction of differentiation in the human HL-60 leukemia cell line by 13-cis-retinoic acid caused a down regulation of OFP synthesis, both intra- and extra-cellular levels dropping to essentially zero. Induction of differentiation with dibutyryl cyclic AMP caused a cessation of secretion of OFP, with a marked increase in its intracellular concentration, a condition resembling the retention in fetal cells. Leukemia cells add to a growing list of tumors previously shown to produce OFP, suggesting that OFP is intimately involved in some facet of tumorigenesis.
authors.affiliation: Department of Veterinary Pathology, Ohio State University, Columbus 43210.
authors.forename: P C
authors.initials: PC
authors.lastname: Stromberg
authors.forename: I
authors.initials: I
authors.lastname: Grants
authors.forename: D E
authors.initials: DE
authors.lastname: Schumm
authors.forename: S
authors.initials: S
authors.lastname: Runge
authors.forename: S
authors.initials: S
authors.lastname: Larroya-Runge
authors.forename: A
authors.initials: A
authors.lastname: Koolemans-Beynen
authors.forename: T E
authors.initials: TE
authors.lastname: Webb
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm / Q000097:blood / Q000235:genetics* / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects; D015536:Down-Regulation / Q000502:physiology; D005455:Fluorescent Antibody Technique; D015973:Gene Expression Regulation, Leukemic / Q000502:physiology; D006801:Humans; D007942:Leukemia, Experimental / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D007951:Leukemia, Myeloid / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D008970:Molecular Weight; D009368:Neoplasm Transplantation; D051381:Rats; D011916:Rats, Inbred F344; D014212:Tretinoin / Q000494:pharmacology; D014407:Tumor Cells, Cultured
chemical_list: D000951:Antigens, Neoplasm; C031192:oncofetal antigens; D014212:Tretinoin